Functional recovery after adult CNS damage is limited in part by myelin inhibitors of axonal regrowth. Three molecules, Nogo-A, MAG, and OMgp, are produced by oligodendrocytes and share neuronal receptor mechanisms through NgR1 and PirB. While each has an axon-inhibitory role in vitro, their in vivo interactions and relative potencies have not been defined. Here, we compared mice singly, doubly, or triply mutant for these three myelin inhibitor proteins. The myelin extracted from Nogo-A mutant mice is less inhibitory for axons than is that from wild-type mice, but myelin lacking MAG and OMgp is indistinguishable from control. However, myelin lacking all three inhibitors is less inhibitory than Nogo-A-deficient myelin, uncovering a redundant and synergistic role for all three proteins in axonal growth inhibition. Spinal cord injury studies revealed an identical in vivo hierarchy of these three myelin proteins. Loss of Nogo-A allows corticospinal and raphespinal axon growth above and below the injury, as well as greater behavioral recovery than in wild-type or heterozygous mutant mice. In contrast, deletion of MAG and OMgp stimulates neither axonal growth nor enhanced locomotion. The triple-mutant mice exhibit greater axonal growth and improved locomotion, consistent with a principal role for Nogo-A and synergistic actions for MAG and OMgp, presumably through shared receptors. These data support the hypothesis that targeting all three myelin ligands, as with NgR1 decoy receptor, provides the optimal chance for overcoming myelin inhibition and improving neurological function.
Introduction
Neurological recovery after trauma to the adult mammalian CNS is limited by the inability of damaged axons to reconnect to their physiological targets. Axon regeneration is restricted by cell-autonomous factors (Bulsara et al., 2002; Szpara et al., 2007) , by the astroglial scar (Yiu and He, 2006; Busch and Silver, 2007) , and by CNS myelin (McGee and Strittmatter, 2003; Liu et al., 2006) . Myelin-derived inhibitory proteins include Nogo-A (Chen et al., 2000; GrandPré et al., 2000; Prinjha et al., 2000) , MAG (McKerracher et al., 1994; Mukhopadhyay et al., 1994) , OMgp (Mikol and Stefansson, 1988 ; K. C. , RGM (Hata et al., 2006) , ephrinB3 (Benson et al., 2005) , semaphorins (Moreau-Fauvarque et al., 2003) , and netrins (Löw et al., 2008) . Of these, Nogo-A, MAG, and OMgp have been studied most extensively. Though they do not share sequence homology, they do share receptor signaling pathways. Neuronal NgR1 binds and transduces signals from Nogo-A, MAG, and OMgp (Fournier et al., 2001; Domeniconi et al., 2002; Liu et al., 2002 ; K. C. Barton et al., 2003; Hu et al., 2005; Venkatesh et al., 2005; Laurén et al., 2007) ; additionally, NgR2 can also mediate MAG signaling (Venkatesh et al., 2005; Laurén et al., 2007) . More recently, PirB has also been shown to bind and transduce signals from all three proteins in vitro (Atwal et al., 2008) . Both NgR1 and PirB are implicated in adult brain plasticity separate from injury (McGee et al., 2005; Syken et al., 2006) .
Though axon-inhibiting roles and receptor mechanisms for Nogo-A, MAG, and OMgp have been demonstrated in tissue culture, their relative contribution to the inhibitory activity associated with CNS myelin in vivo remains undefined. In spinal cord injury (SCI) studies, Nogo-A gene-deficient mice are reported to have increased axonal growth of both sprouting and regenerative patterns (Kim et al., 2003; Simonen et al., 2003) ; however, this phenotype varies with age (Kim et al., 2003; Simonen et al., 2003; Cafferty et al., 2007a) , strain background (Dimou et al., 2006) , genetic mutation Cafferty et al., 2007a; Steward et al., 2007) , and type of lesion (Cafferty et al., 2007b) . Mice deficient in OMgp display limited axon growth after SCI (Ji et al., 2008) , and MAG-deficient mice show no enhancement of axonal growth after SCI (Bartsch, 1996) . Because these proteins have shared receptors and cellular mechanisms, they may be at least partially redundant in myelin for limiting axonal growth after injury.
To assess functional redundancy and axon-inhibitory hierarchy between ligands, we compared mice with single (nogoab ) mutations in these myelin inhibitors. Analysis of myelin-induced inhibition of neurite outgrowth in vitro, axonal growth of corticospinal and raphespinal fibers in vivo, and behavioral studies produce similar findings. Nogo-A plays a demonstrable nonredundant role in limiting axonal growth, whereas MAG/OMgp do not. However, MAG/OMgp have a readily apparent axonal growth limiting effect on a Nogo-A-deficient background consistent with redundant, synergistic axonal growth inhibition.
Materials and Methods
Mice. nogoab trap/trap mice have been described previously (Kim et al., 2003; Cafferty et al., 2007a) and were backcrossed to C57BL/6 for nine generations. This line contains a gene trap insertion in the largest nogoaselective exon and eliminates expression of Nogo-A and Nogo-B protein (Kim et al., 2003) . The magϪ/Ϫ mice were purchased from The Jackson Laboratory (identifier B6.Cg-Mag tm1Rod /J) (Bartsch et al., 1995) and were intercrossed with omgp Ϫ/ Ϫ mice maintained on a C57BL/6 background (Ji et al., 2008) , until homozygote double knock-outs were produced. The omgp Ϫ/ Ϫ mice were a generous gift from Dr. 
, and nogoab wt/trap mag ϩ/ Ϫ omgp ϩ/ Ϫ (n ϭ 20 dorsal hemisection, n ϭ 20 sham lesion) mice were deeply anesthetized with intraperitoneal ketamine (100 mg/kg) and xylazine (15 mg/kg). A laminectomy was performed to expose the dorsal portion of spinal cord corresponding to T6 and T7 levels. The dura mater was pierced, the spinal cord was exposed, and a pledget of gelfoam soaked in 1% lidocaine was placed on the exposed cord for 1 min before lesion. A dorsal hemisection lesion was performed at T6 with a 30 gauge needle and a pair of microscissors to a depth of 1.0 mm to completely sever the dorsal and dorsolateral corticospinal tract (CST). In one cohort of animals, the lesion depth was greater, 1.4 mm, producing a near-total transection. For sham surgery, the laminectomy and exposure were identical, but no spinal cord lesion was created. The overlying muscle and skin was sutured with 4.0 vicryl.
Four weeks after spinal cord injury, mice received unilateral cortical injections with biotin dextran amine (BDA, 10,000 molecular weight, Invitrogen) to anterogradely label the corticospinal tract as described previously (Kim et al., 2003 (Kim et al., , 2004 Cafferty et al., 2007b) . Briefly, burr holes were made over the sensorimotor cortex, and four microinjections were made to a depth of 1.0 mm (coordinates, 0.5-1.5 mm posterior to bregma and 0.5-1.5 mm lateral to bregma) to deliver a total volume of 1.2 l of BDA. Six weeks after dorsal hemisection or sham lesion, mice were perfused with 4% paraformaldehyde. Postfixed overnight at 4°C and embedded in 10% gelatin for immunohistochemical processing.
Four animals were removed from the study due to incomplete lesions as determined by Ͼ50% spared tissue by anti-GFAP staining (1 nogoab trap/trap , 1 mag Ϫ/ Ϫ omgp Ϫ/ Ϫ , and 2 nogoab trap/trap mag
Mice that underwent dorsal hemisection lesions were assessed using the Basso Mouse Score (BMS) scale . All measurements were collected by observers unaware of genotype. Data are presented as average Ϯ SEM. Repeated-measures ANOVA with Tukey post hoc analysis was completed to assess statistical differences between genotypes. Subsequent ANOVA analysis was completed to assess differences between genotypes at each time point after lesion.
Immunoblotting. mice and immediately homogenized in lysis buffer (10 mM Tris/HCl, 1% NP-40, 150 mM NaCl, 0.1% SDS, 1% deoxycholate, supplemented with protease inhibitors) and sonicated, and the supernatant was collected after centrifugation at 100,000 ϫ g for 30 min. Protein (50 g) was separated by SDS-PAGE and blotted onto PVDF. Membranes were probed with antibodies to detect Nogo-A (affinity-purified rabbit antiNogo-A) (X. , MAG (1:1000, R&D Systems), OMgp (1:1000, R&D Systems), NgR1 (1:1000, R&D Systems), myelin basic protein (MBP) (1:2500, Sigma), and GAPDH (1:25,000, Sigma). Immunoreactivity was visualized with anti-rabbit, anti-goat, and anti-mouse IRDye 680-or 800-(1:10,000, Rockland) conjugated secondary antibodies. Protein bands were detected with the Li-Cor Odyssey system (Li-Cor Biosciences) . Neurite outgrowth. Adult wild-type dorsal root ganglia neurons were dissociated as previously described (GrandPré et al., 2000) . Dorsal root ganglion (DRG) cells were cultured in poly-D-lysine-precoated 96-well plates (Biocoat, Becton Dickinson Labware), which had been preincubated with myelin and laminin. Myelin was prepared (Norton and Poduslo, 1973; Robak et al., 2009 ) and extracted with 60 mM CHAPS (Spillmann et al., 1998) before dialysis against 10 mM HEPES, 150 mM NaCl, pH 7.4. One hundred microliters of 10 g/ml extracted myelin from wild-type, nogoab trap/trap , mag Ϫ/ Ϫ omgp Ϫ/ Ϫ , and nogoab trap/trap mag Ϫ/ Ϫ omgp Ϫ/ Ϫ mice and vehicle (dialyzed extraction buffer alone) were incubated in each experimental well of a 96-well tissue culture plate for 2 h at 37°C. Myelin extracts were then aspirated and immediately replaced with 100 l of 10 g/ml laminin (Sigma). After a further 2 h of incubation at 37°C, laminin was aspirated. Wells were washed once with DMEM (Invitrogen) and immediately flooded with culture media (DMEM ϩ B27, Invitrogen) containing dissociated DRG cells. Cells were cultured for 18 h at 37°C and 5% CO 2 , after which time they were fixed by addition of an equal volume of 8% paraformaldehyde in 20% sucrose for 1 h, and then washed with PBS. Cells were stained with antibodies to ␤III-tubulin (1:5000, Promega) and visualized with Alexa Fluor 488-conjugated secondary antibodies. Analysis of neurite outgrowth was completed using ImageExpress automated imaging and neurite measurement algorithms without subjective input from the experimenter. Myelin was prepared independently from four mice of each genotype. Each independent myelin preparation was exposed to wild-type DRG cells from four different mice with each preparation tested in quadruplicate on 4 separate days. Data are presented as mean neurite outgrowth Ϯ SEM from 64 wells for each myelin genotype. In each well, Ͼ50 neurons were measured, and average outgrowth per well was calculated, so that in total Ͼ3000 neurons were included in each measurement.
Histology. Gelatin-embedded brain and spinal cord were cut on a vibratome (Leica Microsystems, VT1000), and free-floating sections were collected and stored in PBS/0.01% sodium azide. Sections (30 m) of brain and spinal cord were immunostained with antibodies to detect myelin (1:200, Brain Stain Kit, Invitrogen), NeuN (1:1000, Millipore), 5-HT (1:5000, Immunostar), and GFAP (1:10,000, DAKO) with appropriate Alexa Flour 488-or 568-(Invitrogen) conjugated secondary antibodies. BDA detection was completed as previously described (Kim et al., 2003) , using a nickel-enhanced diaminobenzidine (DAB) reaction. DAB and immunofluorescent images were collected on a Z1 Imager Zeiss microscope equipped with Apotome (Zeiss).
Anatomical analysis. All anatomical assessments were made by an observer unaware of the genotype.
For quantification of BDAϩ CST axons crossing the midline, five randomly chosen transverse sections of cervical spinal cord were collected from each of 8 -10 mice of each genotype and processed to visualize BDAϩ CST axons with DAB. The average number of crossing fibers was recorded for each animal. Data represents average number of axons clearly crossing through lamina X Ϯ SEM. Statistical significance was assessed using ANOVA with Tukey post hoc analysis.
For quantification of the number of CST fibers growing up to and past the lesion site, half of all the sagittal sections from each mouse (ϳ20 sections) were processed to visualize BDAϩ CST axons with DAB. The sum of axons crossing perpendicular lines at 3 and 1 mm rostral to the lesion and 0, 1, 2, and 3 mm caudal to the lesion was recorded in all 20 sections from each animal. Data represent the average raw number of axons Ϯ SEM. Statistical significance was assessed using ANOVA with Tukey post hoc analysis.
The density of 5-HT-IR raphespinal innervation of ventral horn was determined using NIH ImageJ version 1.62. Labeled fibers were selected by thresholding, and average fiber length within gray matter was measured after using the skeletonize function in five sections from each mouse. Data represents average 5-HT density Ϯ SEM/ genotype. Statistical significance was assessed using ANOVA with Tukey post hoc analysis.
Lesion depth was assessed in five sagittal sections from each lesioned mouse using GFAP immunoreactivity to delineate the lesion margins. We measured the dorsoventral extent of hyperfilamentous GFAP-IR for each animal. Animals that illustrated Ͻ50% hyperfilamentous GFAP-IR in the dorsoventral axis were removed from the study (one NMOϪ/Ϫ mouse and two NMOϩ/Ϫ mice). Data represents average GFAP-IR depth Ϯ SEM/genotype. Statistical significance was assessed using ANOVA with Tukey post hoc analysis.
Results

Mice lacking Nogo-A/B, MAG, and OMgp are viable and display normal CNS architecture
To ascertain the interactions and the relative potencies of Nogo, MAG, and OMgp to inhibit axon growth, we generated single-, double-, and triple-null mutant mice for Nogo (NϪ/Ϫ), MAG/OMgp (MOϪ/Ϫ), and Nogo/MAG/OMgp (NMOϪ/Ϫ), respectively. The mag Ϫ/Ϫ mice (Bartsch et al., 1995) were bred with omgp Ϫ/Ϫ mice (Ji et al., 2008) and backcrossed until homozygote double mutants were generated. Progeny from mag/omgp double knock-outs were intercrossed with the nogoab trap/trap mice (Kim et al., 2003; Cafferty et al., 2007a) Discrete myelin abnormalities at particular ages have been reported for each of these three mutant strains (Li et al., 1994; Montag et al., 1994; Bartsch, 1996; Huang et al., 2005; Pernet et al., 2008) , so we considered whether the double-or triple-mutant mice might display more pronounced abnormalities in overall CNS myelination. Regional pat- Synergistic CNS myelin inhibition of neurite outgrowth by MAG/OMgp is revealed in absence of Nogo-A CNS myelin inhibition of neurite outgrowth from CNS or PNS neurons is readily detected in tissue culture (Schwab and Thoenen, 1985; Savio and Schwab, 1989 omgp Ϫ/ Ϫ mice and dialyzed extraction buffer (vehicle) had been adsorbed without dehydration. DRG cells grown on plates coated with vehicle extend neurites with an average total length of 192.5 Ϯ 11.6 m ( Fig. 1 A, F ), while cells grown on wild-type myelin exhibit significantly reduced outgrowth with average total neurite length per well of 76.5 Ϯ 13.5 m (Fig. 2 B, F ) (*p Ͻ 0.01, ANOVA). Myelin prepared from mag (Fig. 2C,F ) exhibit a nonsignificant trend to less inhibition than wild-type myelin, suggesting that these proteins may have little role in myelin inhibition. In contrast, myelin prepared from nogoab trap/trap mice is significantly less inhibitory for DRG neurite outgrowth in comparison to wild-type (132.9 Ϯ 11.8 m vs 76.5 Ϯ 13.5 m, **p Ͻ 0.01, ANOVA) and mag
Ϫ/ Ϫ myelin (132.9 Ϯ 11.8 m vs 99 Ϯ 10 m, **p Ͻ 0.01, ANOVA) (Fig. 2 D, F ) , demonstrating an independent and predominant role for Nogo in myelin inhibition.
Because Nogo, MAG, and OMgp each interact with both NgR1 and PirB axonal receptors, we considered whether MAG and OMgp action might be uncovered in the absence of Nogo-A. Myelin prepared from nogoab trap/trap mag Ϫ/ Ϫ omgp Ϫ/ Ϫ mice is significantly less inhibitory to neurite outgrowth (Fig. 2 E, F # p Ͻ 0.01, ANOVA). Thus, the triplemutant preparation reveals a synergistic or ancillary role for MAG and OMgp in myelin limitation of axonal outgrowth on the Nogo-null background.
Rostral CST sprouting after dorsal hemisection in myelin inhibitor mutant mice
We sought to determine whether a similar relationship between Nogo/MAG/OMgp genotype and axonal growth exists in vivo after traumatic injury. Dorsal hemisection (DhX) of the thoracic spinal cord results in interruption of many descending motor and ascending sensory spinal tracts, such that lesioned mice lose function in their hindlimbs. Restoration of hindlimb function depends largely on the reestablishment of axonal communication across the spinal cord injury site, either directly via long distance growth of injured fibers around or through the lesion site, or indirectly through local growth of injured and intact fibers to create new bypass circuits. We assessed the contribution of Nogo, MAG, and OMgp to these various patterns of axon growth and recovery. As a first step toward evaluating these multiple mechanisms, we measured the local growth of CST axons within the cervical enlargement at levels C5-C8, several millimeters rostral to the lesion in mice of multiple genotypes. We labeled the CST via BDA microinjection into the right motor cortex (supplemental Fig. S1 , available at www.jneurosci.org as supplemental material). Uninjured intact wild-type (Fig. 3 A, B) , nogoab trap/trap (Fig. 3 E, F ) , mag (Fig. 3C,D) , and nogoab trap/trap mag (Fig. 3G ,H ) mice displayed normal CST fasciculation in the ventral dorsal columns, termination of fibers in gray matter, and the sparse presence of fibers in the dorsolateral funiculi (Fig. 3A-H (Fig. 3Q, black bars) . Six weeks after DhX, a small number of lesioned BDAϩ fibers are seen crossing the midline in wild-type (Fig. 3 I, J ) and mag (Fig. 3 K, L) mice; however, the number differs insignificantly from sham-lesioned littermates (Fig. 3Q) . Thus, injury may produce minor degrees of CST sprouting, but the absence of MAG and OMgp does not alter this growth, paralleling the neurite outgrowth assays in the presence of myelin (Fig. 2) .
In contrast to control mice, nogoab trap/trap mice exhibit significantly increased numbers of BDAϩ CST fibers crossing the midline after DhX in comparison to intact and lesioned wild-type or mag Figure S2 (available at www.jneurosci.org as supplemental material). Thus, the absence of MAG/OMgp increases a Nogo-deficient postinjury axonal sprouting phenotype, and this matches the in vitro myelin inhibition of axonal growth (Fig. 2) . A, C, E, G, I, K,  M, O), 500 m; B (for B, D, F, H, J, L, N, P) , 100 m. fibers in sagittal sections spanning a T8 dorsal hemisection (Fig.  4 A-P) . The CST fails to grow caudal to the DhX in wild-type mice (Fig. 4 A) . CST axons are seen at the lesion perimeter, and most of these axons exhibit dystrophic end bulbs characteristic of abortive regeneration (Fig. 4 Aii, arrows) (Silver and Miller, 2004) . Camera lucida reconstruction of serial sagittal sections through the lesion site illustrates the absence of BDAϩ CST axons caudal to the lesion (Fig. 4 B) in wild-type mice after DhX, and the same phenotype was observed in nogoab WT/trap mag ϩ/ Ϫ omgp ϩ/ Ϫ mice (Fig. 4C,D) and mag (Fig. 4G,H ) . Significant numbers of regenerating BDAϩ CST fibers were observed growing at 1, 2, and 3 mm past the lesion site in nogoab trap/trap (Fig. 4E,F (Fig. 5A-J ) . Photomicrographs A, C, E, and G are projection images of four sagittal sections and represent four regions of spinal cord depicted in schematic. The green represents the cen- tral zone (mostly dorsal and ventral column white matter and central canal), blue the medial zone (mostly dorsal and ventral gray matter), yellow the mediolateral zone (gray Ͼ white matter), and red the lateral zone (gray Ͻ white mater). Camera lucida reconstructions B, D, F, and H represent each of the collapsed images in the projection in a distinct color. Most axons caudal to the lesion site appear in zones with a greater percentage of white matter. The percentage of BDAϩ CST axons observed in white matter 2 mm caudal to the lesion site in nogoab trap/trap mag Ϫ/ Ϫ omgp Ϫ/ Ϫ mice is 62.1 Ϯ 1.4% (n ϭ 9, ϮSEM). To confirm that the large number of axons present at and past the lesion site (Fig. 5 K, L) reflect regenerative growth, we immunostained sagittal sections of spinal cord from each of the four zones with GFAP to observe the extent of injury-induced astrocyte activation (see below). The GFAP-IR images were projected onto the camera lucida reconstruction of axonal growth (Fig. 5I ) to demarcate the lesion site relative to regenerating axons (Fig.  5J ) . GFAP-IR can be seen extending from the dorsal surface of the spinal cord to below the central canal (Fig. 5 J, O) . Thus, reconstruction demonstrates that CST fibers regenerate extensively into white matter greater than gray matter in the caudal spinal cord of nogoab trap/trap mag Ϫ/ Ϫ omgp Ϫ/ Ϫ mice.
CST regeneration after dorsal hemisection in
Raphespinal regeneration after dorsal hemisection in nogoab trap/trap mag Ϫ/Ϫ omgp Ϫ/Ϫ mice The DhX injury damages multiple spinal tracts in addition to the CST, including the serotonergic raphespinal tract (RST). The RST contributes significantly to locomotion (Lemon, 2008) . To determine whether the growth of raphespinal axons is differentially sensitive to the presence of Nogo-A/B, MAG, and OMgp, we assessed the growth pattern of the RST after DhX in wild-type, nogoab trap/trap , mag
, and nogoab trap/trap mag Ϫ/ Ϫ omgp Ϫ/ Ϫ mice. 5-HT-immunoreactive (5-HT-IR) RST axons originating in the brainstem descend bilaterally in the lateral columns and densely innervate both dorsal and ventral gray matter at all spinal levels. We focused our analysis on the ventral horn of the lumbar spinal cord, where the RST is known to synapse on motor neurons (Mason, 2001) . 5-HT-IR axons are observed to ramify densely in the L4/5 ventral horn of shamlesioned wild-type and nogoab trap/trap mag Ϫ/ Ϫ omgp Ϫ/ Ϫ mice (Fig. 6 A, B) . DhX at T8 significantly reduces the density of 5-HT-IR by 75% in wild-type (Fig. 6C, D (Fig. 6 I-K ) . The intact RST innervation likely reflects caudal sprouting of these fibers after the injury to restore normal fiber density. As for other measures, there is no regenerative phenotype in mag Ϫ/ Ϫ omgp Ϫ/ Ϫ mice, but the partial phenotype in the nogoab trap/trap mice is enhanced by deletion of MAG and OMgp. Locomotor recovery in nogoab trap/trap mag Ϫ/Ϫ omgp Ϫ/Ϫ mice after SCI The primary outcome in this study is the degree of axonal growth after spinal lesion in mice of different genotypes. However, we also scored functional outcomes by observing locomotion in the open field for each cohort. Standardizing lesion severity in experimental SCI models is crucial to correlating anatomical with functional outcomes. Therefore, we assessed lesion depth in animals that underwent dorsal hemisection (Fig. 7A-D) , using GFAP immunoreactivity. Wild-type, nogoab trap/trap (Fig. 7A) , mag (Fig.  7C) , and nogoab WT/trap mag (Fig. 7D) mice display equivalent induction of GFAP at the lesion site 5 weeks after lesion. The percentage of GFAP-negative spared spinal tissue in the remaining groups of animals is insignificantly different between genotypes (Fig. 7E) .
Mice behavior was assessed on day 3 before lesion, and 6 h and 3, 7, 14, 21, and 28 d after lesion (Fig. 7F-J (Fig. 7I ) . Therefore we pooled the control groups (Fig. 7J ) omgp ϩ/ Ϫ that had a more severe, neartotal transection lesion due to deeper cutting at the time of surgery. Such mice preserve Ͻ10% of tissue (Fig. 8 A-D (Fig. 8E ) (repeated-measures ANOVA, p Ͻ 0.001).
Discussion
The major conclusions from this work are that Nogo-A is the myelin inhibitor with the greatest inhibitory activity, and that MAG and OMgp play synergistic roles in preventing axonal growth in the adult mammalian CNS. These conclusions are supported by analysis of axonal outgrowth in vitro on substrates coated with myelin prepared from mice of various mutant genotypes. The MAG/OMgp mutant myelin is as inhibitory as wildtype myelin. The reduced inhibition generated by deletion of Nogo-A is enhanced by deletion of MAG/OMgp as well. A similar synergy of MAG plus OMgp with Nogo-A is observed in spinal cord-injured mice through examination of rostral CST sprouting, CST regeneration across the lesion, caudal RST sprouting, and locomotor recovery. We conclude that Nogo-A is a principal myelin inhibitor, with a redundant and synergistic role for MAG plus OMgp.
Relative inhibitory activity of CNS myelin components
The myelin extracted from mag Ϫ/ Ϫ omgp Ϫ/ Ϫ mice is as inhibitory as wild-type myelin in neurite outgrowth from wild-type DRG neurons. We chose to use sensory neurons as they express NgR1 (Fournier et al., 2001 ), NgR2 (Venkatesh et al., 2005) , Lingo-1 (Mi et al., 2004 ), p75 (McMahon et al., 1994 , TAJ/ TROY (Park et al., 2005; Shao et al., 2005) , and PirB (Atwal et al., 2008) , all the receptor components that have been reported necessary to transduce Nogo-A, MAG, and OMgp binding. The lack of significant disinhibition observed on myelin from mag Ϫ/ Ϫ omgp Ϫ/ Ϫ mice may be due to our extraction protocol, which may have failed to collect the axogliasome OMgp-rich fraction (Huang et al., 2005) . However, previous studies have also reported a lack of enhanced neurite outgrowth of DRG cells grown on 1 g of extracted myelin from mag Ϫ/ Ϫ (Bartsch et al., 1995; Ng et al., 1996) and omgp Ϫ/ Ϫ (Ji et al., 2008) mice. Both of these studies concluded that other inhibitors present in CNS myelin mask the potential benefit that removing either one of these two proteins would otherwise show. Accordingly, we compared the outgrowth-inhibitory activity of myelin from nogoab trap/trap and nogoab trap/trap mag Ϫ/ Ϫ omgp Ϫ/ Ϫ mice. As previously reported (Kim et al., 2003; Simonen et al., 2003; Zheng et al., 2003) , we find that myelin extracted from nogoab Ϫ/ Ϫ mice was less inhibitory to neurite outgrowth than myelin from wild-type mice. Critically, we find that nogoab trap/trap mag myelin. It should be noted that we used a detergent extraction protocol for isolating myelin. This may explain why there is no remaining inhibition from other proteins reported to be associated with crude myelin, such as ephrinB3 (Benson et al., 2005) and netrin-1 (Löw et al., 2008) . Under these assay conditions, Nogo-A, MAG, and OMgp fully account for CNS myelin inhibition of axonal outgrowth.
Enhanced sprouting and regeneration of lesioned CST and RST in vivo
In accord with previous reports for single mag Ϫ/ Ϫ (Bartsch et al., 1995) and omgp Ϫ/ Ϫ (Ji et al., 2008 ) mice, we fail to observe growth of CST axons above the lesion, or of CST plus RST axons below the lesion after dorsal hemisection in wild-type or mag
In line with our previous data, we find that nogoab trap/trap mice display a significantly greater number of CST axons sprouting above the lesion and regenerating past the lesion (Kim et al., 2003; Cafferty et al., 2007a) , as well as enhanced RST innervation of the lumbar ventral horn. Most importantly, these phenotypes are augmented in nogoab trap/trap mag
mice. Thus, the in vivo anatomical outcome from SCI exactly parallels the in vitro axonal outgrowth results with regard to the relative roles of Nogo-A, MAG, and OMgp. Although the primary focus of these studies was axonal outgrowth inhibition by myelin, we also monitored BMS scores as a neurological outcome after SCI. As in the axonal assays, the mag Ϫ/ Ϫ omgp Ϫ/ Ϫ mice behave indistinguishably from wild-type or heterozygous controls. Despite this lack of direct effect, MAG . The zone of overt of glial scarring at the lesion site shows regenerative growth, although this is less prolific than the axonal sprouting far from the lesion. The greater degree of plasticity-linked sprouting than frank regeneration is consistent with the deletion of myelin inhibitors not altering the inhibitory extracellular matrix enriched at the lesion site (for review, see Busch and Silver, 2007) . Furthermore, many other inhibitory proteins that were not targeted in this study remain in nogoab trap/trap mag Ϫ/ Ϫ omgp Ϫ/ Ϫ mice, including ephrinB3 (Benson et al., 2005) , netrin-1 (Löw et al., 2008) , SEMA6A (Rü nker et al., 2008) , SEMA4D (Moreau-Fauvarque et al., 2003) , and RGMa (Hata et al., 2006) .
Other physiological functions for MAG and OMgp
Previous evaluation of mag Ϫ/ Ϫ and omgp Ϫ/ Ϫ mice has identified important roles for these proteins separate from function as inhibitors of neurite outgrowth. MAG is crucial for the initiation and maintenance of myelination in the CNS. Consistent with MAG localization to paranodal regions, ultrastructural analysis of mag Ϫ/ Ϫ mice demonstrates redundant myelin loops, supernumerary myelin sheaths, and disorganization of the axoglial junctions in the paranodal regions (for review, see Bartsch, 1996) . Signaling downstream of MAG in oligodendrocytes may require specific splice forms of the MAG cytoplasmic tail and Fyn activation (Fujita et al., 1998; Biffiger et al., 2000) .
OMgp was originally identified as being enriched in CNS white matter (Vourc'h and Andres, 2004) , and is expressed by both oligodendrocytes and neurons (Huang et al., 2005) . OMgp has been shown to have an anti-proliferative effect when overexpressed in NIH3T3 cells (Habib et al., 1998 ) via a PDGFdependent mechanism. PDGF is a known oligodendrocyte precursor cell (OPC) mitogen (Wolswijk et al., 1991) ; hence, OMgp could determine OPC proliferation and subsequent differentiation. A recent study has also implicated OMgp in maintaining the stability of node of Ranvier, where it additionally may restrict aberrant axonal sprouting (Huang et al., 2005) .
Nogo-A has also been reported to play a role in the developmental timing of myelination (Pernet et al., 2008) . Despite these varied myelin phenotypes for Nogo, MAG, and OMgp, there is no overt deficit at the light microscopy level in myelination or oligodendrocytes in adult triple-mutant mice. Thus, these roles in myelin formation are unlikely to occur via shared synergistic mechanisms. Consistent with independent roles for these three proteins in myelination, no myelin phenotype has been reported for NgR1-null mice.
Implications for spinal cord injury therapy
In light of the data presented here and the mild axon regenerative phenotype observed in both mag Ϫ/ Ϫ and omgp Ϫ/ Ϫ mice, it is clear that Nogo-A is the most potent NgR1/PirB ligand expressed in the adult spinal cord. Indeed, targeting Nogo-A pharmacologically Schwab, 1990, 1993; Bregman et al., 1995; Brösamle et al., 2000; Liebscher et al., 2005) has been shown to enhance axonal regeneration and functional recovery after SCI in rodents. Genetic evidence to support the fact that Nogo-A is a key inhibitor of axonal regeneration has been less consistent; some studies report significant axonal growth after SCI in nogo Ϫ/ Ϫ mice (Kim et al., 2003; Simonen et al., 2003; Dimou et al., 2006) , while others fail to observe this phenotype Lee et al., 2009) . While there may be uncertainty regarding the variables influencing the phenotypes of various nogo Ϫ/ Ϫ mice, such as the age of lesioned mice, background strain of mice, and nature of the mutant allele Dimou et al., 2006; Cafferty et al., 2007a; Steward et al., 2007) , the efficacy of anti-Nogo-A therapies has been reported in nonhuman primate SCI models (Freund et al., 2006 (Freund et al., , 2007 (Freund et al., , 2009 Beaud et al., 2008) and is being tested now in the clinic.
While the current studies do not support separate targeting of either MAG or OMgp as a means to promote neurological recovery, they do demonstrate a clear benefit in all assays for targeting the three myelin ligands as a group rather than simply targeting Nogo-A alone. The molecular basis for this synergy is likely the shared receptors, NgR1 and PirB. The only published method for targeting all three ligands is the NgR1 decoy receptor Li et al., 2004 Li et al., , 2005 . Of note, the degree of CST axonal growth and neurological benefit observed after NgR(310)ecto-Fc treatment of dorsal hemisected rats was greater than with antiNogo antibody treatment (Li et al., 2004; Liebscher et al., 2005) . Although these two studies were conducted in different laboratories, the results parallel those observed in the Nogo-A, MAG, OMgp triple mutant as compared to the Nogo-A single-mutant mouse studies here. The greater benefit of targeting all three ligands may also explain the benefit of NgR(310)ecto-Fc treatment for spinal contusion recovery (Wang et al., 2006) in the absence of any report of benefit for anti-Nogo treatment of spinal contusion injury.
We conclude that combined targeting of NgR1/PirB ligands promotes axonal regeneration and functional recovery to a certain point. Surmounting this threshold will require targeting additional inhibitory proteins present in CNS, while concomitantly addressing the low intrinsic growth capacity of CNS neurons.
